Discontinuation report ELTROXIN
| Report ID | 113481 |
| Drug Identification Number | 02213230 |
| Brand name | ELTROXIN |
| Common or Proper name | Eltroxin 300 mcg |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | LEVOTHYROXINE SODIUM |
| Strength(s) | 300MCG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 500 tablets |
| ATC code | H03AA |
| ATC description | THYROID PREPARATIONS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2018-07-24 |
| Remaining supply date | 2018-07-23 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2030 BRISTOL CIRCLE, SUITE 201 OAKVILLE, ONTARIO CANADA L6H 0H2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2020-04-29 | French | Compare |
| v1 | 2020-04-29 | English | Compare |
Showing 1 to 2 of 2